Organs dosimetry in targeted radionuclide therapy-Reference-Cited by-同舟云学术

Organs dosimetry in targeted radionuclide therapy

Published:2021-11 Issue: Volume:188 Page:109668
ISSN:0969-806X
Container-title:Radiation Physics and Chemistry
language:en
Short-container-title:Radiation Physics and Chemistry

Author:

Alnaaimi Meshari,Sulieman Abdelmoneim,Alkhorayef Mohammed,Salah Hasan,Alduaij Musa^ORCID,Algaily Mosab,Alomair O.,Alashban Y.,Almohammad H.I.,Bradley David^ORCID,Kappas C.

Funder

King Saud University

Publisher

Elsevier BV

Subject

Radiation

Reference17 articles.

1. Dosimetry for (177)Lu-DKFZPSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer;Delker;Eur. J. Nucl. Med. Mol. Imag.,2016

2. Evaluation of radiation safety in (177)Lu-PSMA therapy and development of outpatient treatment protocol;Demir;J. Radiol. Prot.,2016

3. Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT?;Esser;Eur. J. Nucl. Med. Mol. Imag.,2006

4. Targeted radionuclide therapy: a historical and personal review;Goldsmith;Semin. Nucl. Med.,2020

5. [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study;Hofman;Lancet Oncol.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient organ dose during multicycle radiation dosimetry in Lutetium −177 radionuclide therapy;Radiation Physics and Chemistry;2024-11

2. Evaluation of uptake values of FDG: Body surface area Vs. body weight correction;Radiation Physics and Chemistry;2022-11

3. Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology;EJNMMI Radiopharmacy and Chemistry;2022-04-25